Former DEA Attorney Jason Hadges Joins Hogan Lovells
Hogan Lovells announced that Jason Hadges will join the firm’s Government Regulatory practice group as a partner in the Washington D.C. office, working in the firm’s Pharmaceuticals and Biotechnology Regulatory Practice.
“There are few attorneys with the substantial first-hand regulatory experience that Jason has gained throughout his career at DEA and FDA,” said Alice Valder Curran, Head of Hogan Lovells Government Regulatory Practice Group. “His deep knowledge and familiarity with the relevant laws, agency policies and precedents will offer our life sciences clients a particularly informed perspective on regulatory issues, especially with regard to enforcement actions.”
Hadges joins the firm after five years in the Office of Chief Counsel of the US Drug Enforcement Administration (DEA), where he was a senior attorney in the Diversion and Regulatory Litigation Section. Before DEA, Hadges spent more than eight years at the Food and Drug Administration (FDA), as an Associate Chief Counsel in the Office of Chief Counsel, where he focused on criminal enforcement and counseling FDA’s Office of Criminal Investigations. During that period he also served as a Special Assistant US Attorney on a number of prosecutions. His legal career started as a criminal defense attorney in the US Navy Judge Advocate General’s Corps.
“Jason’s experience, coupled with his keen analytical skills and practical, results-oriented approach, will be a significant addition to our enforcement and compliance capabilities, especially with regard to controlled substances, but also pharmaceutical products more broadly,” said Philip Katz, chair of the firm’s Pharmaceuticals and Biotechnology Practice. “DEA and FDA compliance is a large and growing part of our work, both anticipatorily and in response to agency inspections and enforcement actions. Jason joins and further bolsters the strong team we have in place, and allows us to do even more for our clients around the globe.”
“I am looking forward to joining and collaborating with the Hogan Lovells lawyers, who are well known for providing smart, creative, and practical advice to the complex legal issues faced by their pharmaceutical and biotechnology clients,” said Hadges. “Our shared goal is to continue expanding the firm’s ability to provide knowledgeable counsel and advocacy to help clients successfully operate businesses in highly regulated environments, and I’m excited to get started.”
Hadges earned his J.D., summa cum laude, from The American University, Washington College of Law and a B.A. from Duke University.
